Elequin Capital’s Bruker Corporation 6.375% Series A Preferred Stock BRKRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Buy
4,783
+3,635
+317% +$1.31M 0.06% 83
2026
Q1
$303K Buy
1,148
+1,062
+1,235% +$346K 0.03% 91
2025
Q4
$31.4K Buy
+86
New +$29K ﹤0.01% 167

Other funds holding BRKRP

Elequin Capital's BRKRP Position: Q2 2026 in Review

Elequin Capital increased its Bruker Corporation 6.375% Series A Preferred Stock (BRKRP) stake by 317% in Q2 2026, buying an estimated $1.31M and bringing the position to 4,783 shares worth $2.13M. The position accounts for 0.06% of the portfolio, ranked #83.

Elequin Capital first reported a position in BRKRP in Q4 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold BRKRP as of Q2 2026.

  • Elequin Capital held 4,783 shares of Bruker Corporation 6.375% Series A Preferred Stock worth $2.13M as of Q2 2026.
  • Elequin Capital bought 3,635 Bruker Corporation 6.375% Series A Preferred Stock shares in Q2 2026, an estimated $1.31M.
  • Bruker Corporation 6.375% Series A Preferred Stock made up 0.06% of Elequin Capital's portfolio in Q2 2026, its #83 holding.
  • Elequin Capital first reported a position in Bruker Corporation 6.375% Series A Preferred Stock in Q4 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Bruker Corporation 6.375% Series A Preferred Stock as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.